Cytel: Global experts in Market Access, HEOR & RWE

At Cytel, we provide the deep insights and expertise necessary for making confident development decisions. Our global team helps generate evidence that complements traditional randomized clinical trials, accelerates submissions, expands indications, and supports health-economic decision-making.

We are excited to see you at ISPOR Europe 2023 on the 12th - 15th November where, once again, Cytel is honored to have the greatest number of Issue Panels & Workshop presentations, a testament to our commitment as a scientific and methodological leader. This year, visit us at Booth #C3-049 to connect with our HEOR & RWE experts on topics such as RWE and Health Disparities in HTAs, Quantitative Bias Analysis, RWE Sources in HTA Submissions and more.

Fill out the form to pre-book a meeting with the Cytel team to learn more about our innovative offerings in Market Access, HEOR & RWE.

Meet with us at ISPOR Europe

HEOR & RWE Focused Blogs

Mind the Health Gap: Is It Time to Reliably Measure the Impact of Health Inequity in Product Development and Assessment? Yes, It Is.

Written by Grammati Sarri and Yannis Jemiai The spotlight for this year’s World Evidence-Based Healthcare Day (EBHC)...

Looking to the Future — Improving Diagnosis and Prognosis of Eye Conditions with Artificial Intelligence

Written by Alind Gupta, Cytel; Haridarshan Patel, Horizon Therapeutics; and Jason Simeone, Cytel Ophthalmology is...

Global Planning to Local Execution Market Success

Moving beyond static evidence development to ensure local market access success; responding to recent changes in...

Real World & Advanced Analytics

Through our advanced analytics, Cytel provides the richer, deeper insights necessary for making confident development decisions. We generate evidence which complements traditional randomized clinical trials, accelerates submissions, expands indications, and supports health-economic decision-making.

Click to learn more about our HEOR, RWE, LiveSLR, and more offerings.

Cytel Market Access, HEOR & RWE